Chronic Disease News and Research

RSS

World of digital health changing global healthcare landscape

The 4th Mobile and Wearable Technology: Healthcare 2014 Conference will be taking place from 3 – 4 April 2014 in Singapore at the Parkroyal Hotel.

From Medtronic 28 Mar 2014

PrescribeWellness and APhA Foundation join forces to provide community pharmacies

At the American Pharmacists Association (APhA) Convention here today, PrescribeWellness announced a partnership with the APhA Foundation to provide community pharmacies new tools to help their diabetic patients improve their disease management and health.

27 Mar 2014

Higher exposure to TRAP increases odds of readmission to hospital for asthma

Higher exposure to traffic-related air pollution (TRAP) dramatically increases the odds of readmission to the hospital for asthma - but only for white children, according to a new Cincinnati Children's Hospital Medical Center study.

27 Mar 2014

Enrollment push is tough in Mississippi

Politico reports on efforts to sign people up for health care as Humana sends a lime green bus through some of the state's poorest areas. Other outlets look at enrollment campaigns in Maine, California, Connecticut, Minnesota, Oregon and Colorado.

25 Mar 2014

First Edition: March 24, 2013

Today's early morning highlights from the major news organizations examine the final week for health law enrollment, the Supreme Court case this week about the law's contraceptive mandate and the fourth anniversary of the enactment of the controversial overhaul.

24 Mar 2014

Treat or eat: Many people forced to choose between food or medicine

Chronically ill adults who reported food insecurity in their household (not having consistent access to food due to lack of financial stability) were significantly more likely to report cost-related medication underuse, according to a new study in The American Journal of Medicine,. The term cost-related medication underuse refers to taking less medication than prescribed, or not taking it at all due to financial concerns.

21 Mar 2014

Non-alcoholic steatohepatitis (NASH): an interview with Jean-François Mouney, CEO of Genfit

The progressive form of Non-Alcoholic Fatty Liver Disease (NAFLD) is Non-Alcoholic Steatohepatitis (NASH), which defines a subgroup of NAFLD where liver steatosis co-exists with cell injury (hepatocyte ballooning) and inflammation with or without fibrosis at histological examination.

18 Mar 2014

Research on diverse health benefits of oats in protecting heart

Eleven top scientists from around the globe presented the latest findings on the powerful compounds found in oats in a scientific session titled, Physicochemical Properties and Biological Functionality of Oats, at the 247th Annual Conference of the American Chemical Society in Dallas, TX

17 Mar 2014

Viewpoints: No reason to delay health law; GOP may need an alternative message; shrinking abortion options

HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.

11 Mar 2014

Research roundup: Health care and prisoners; hospitalized patients' surrogates; suicides in the army

As a group, jail-involved individuals, which we define here as people with a history of arrest and jail admission in the recent past, carry a heavy illness burden, with high rates of infectious and chronic disease as well as mental illness and substance use.

10 Mar 2014

Proteus Digital Health teams up with leading organisations to bring digital health technology to the UK

Leading digital medicines company Proteus Digital Health is partnering with Eastern Academic Health Science Network, The Northern Health Science Alliance and Oxford University, Oxford University Hospitals NHS Trust and Oxford Academic Health Science Network to bring digital health technology and global operations and manufacturing to the UK.

10 Mar 2014

Boston Heart Diagnostics announces commercial launch of FDA-cleared MPO test

Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, announced the commercial launch of an FDA-cleared MPO (myeloperoxidase) test, a key biomarker for inflammation. Studies show that MPO levels are useful predictors of near-term (one to six months) risk of heart attack or stroke.

6 Mar 2014

The Alliance to End Hunger, Promedica to host summit on hunger and health

ProMedica, a nonprofit healthcare organization serving northwest Ohio and southeast Michigan, is partnering with the Alliance to End Hunger to host Come to the Table, a summit in Washington, D.C., to broaden the dialogue nationally about addressing hunger as a health issue.

25 Feb 2014

University of Iowa study finds that police work, like many other jobs, is mostly sedentary

Are you active at your job? If you're like most workers, you probably aren't. And the consequences could be deadly.

20 Feb 2014

Global environmental variation produces variation in human biology around the world

Three anthropology professors from the Weinberg College of Arts and Sciences at Northwestern University will highlight recent research in biological anthropology Sunday, Feb. 16 at the annual meeting of the American Association for the Advancement of Science in Chicago.

17 Feb 2014

Researchers use new technique that can partially move tumors from inoperable locations in brain

One factor that makes glioblastoma cancers so difficult to treat is that malignant cells from the tumors spread throughout the brain by following nerve fibers and blood vessels to invade new locations.

17 Feb 2014

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

Four-year results of the Zilver PTX Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease continue to demonstrate consistent, superior results when compared to bare metal stents (BMS) and percutaneous transluminal angioplasty (PTA) in terms of primary patency, restenosis reduction and revascularization rates.

From COOK MEDICAL INC. 14 Feb 2014

Healthways reports net loss of $5.3 million in Q4 2013

Ben R. Leedle, Jr., president and chief executive officer of Healthways, Inc., today announced financial results for the fourth quarter and year ended December 31, 2013. Total revenues for the quarter were $169.2 million compared with $175.2 million for the fourth quarter of 2012.

13 Feb 2014

SWHR comments on CBS 60 Minutes segment on how drugs uniquely affect men and women

The Society for Women's Health Research is the leading voice on research into the biological differences between women and men. SWHR President and CEO Phyllis Greenberger comments on the CBS 60 Minutes segment that aired February 9 on how drugs uniquely affect men and women

11 Feb 2014

Combination of SYK and FLT3 enzymes promotes progression of acute myelogenous leukemia

Reinforcing the need to look beyond genomic alterations to understand the complexity of cancer, researchers from Dana-Farber/Boston Children's Cancer and Blood Disorders Center report that a normal enzyme called SYK pairs with FLT3, the most commonly mutated enzyme found in acute myelogenous leukemia (AML), to promote progression of the disease.